Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy

Clinical Cancer Research

Volumn 14, Issue 19, 2008, Pages 6284-6288

  Azria, David ^a,b   Ozsahin, Mahmut ^c   Kramar, Andrew ^b   Peters, Sheila ^d   Atencio, David P ^d   Crompton, Nigel E A ^f   Mornex, Françoise ^g   Pèlegrin, André ^a   Dubois, Jean Bernard ^a,b   Mirimanoff, René Olivier ^c   Rosenstein, Barry S ^d,e  

^a INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^b CENTRE VAL D AURELLE   (France)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f VAN ANDEL RESEARCH INSTITUTE   (United States)

^g CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; PROTEIN SOD2; TRANSFORMING GROWTH FACTOR BETA; TUMOR PROTEIN; UNCLASSIFIED DRUG; XRCC1 PROTEIN; XRCC3 PROTEIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CD8+ T LYMPHOCYTE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DNA ISOLATION; GENETIC SCREENING; GENOTYPE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MENINGIOMA; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION INJURY; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; FIBROSIS; GENETIC PREDISPOSITION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; RADIATION DOSE; RADIOTHERAPY; RISK; TIME; TREATMENT OUTCOME;

APOPTOSIS; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; FIBROSIS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 58149144774     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-0700     Document Type: Article

References (27)

1. Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003;4:529-36.
2. Aziz NM. Cancer survivorship research: state of knowledge, challenges and opportunities. Acta Oncol 2007;46:417-32.
3. Ho AY, Atencio DP, Peters S, et al. Genetic predictors of adverse radiotherapy effects: the Gene-PARE project. Int J Radiat Oncol Biol Phys 2006;65:646-55.
4. Ozsahin M, Crompton NE, Gourgou S, et al. CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res 2005;11:7426-33.
5. Crompton NE, Miralbell R, Rutz HP, et al. Altered apoptotic profiles in irradiated patients with increased toxicity. Int J Radiat Oncol Biol Phys 1999;45:707-14.
6. Crompton NE, Ozsahin M. A versatile and rapid assay of radiosensitivity of peripheral blood leukocytes based on DNA and surface-marker assessment of cytotoxicity. Radiat Res 1997;147:55-60.
7. Crompton NE, Shi YQ, Emery GC, et al. Sources of variation in patient response to radiation treatment. Int J Radiat Oncol Biol Phys 2001;49:547-54.
8. Ozsahin M, Ozsahin H, Shi Y, Larsson B, Wurgler FE, Crompton NE. Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. Int J Radiat Oncol Biol Phys 1997;38:429-40.
9. Svensson JP, Stalpers LJ, Esveldt-van Lange RE, et al. Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med 2006;3:e422.
10. Hall EJ, Schiff PB, Hanks GE, et al. A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Cancer J Sci Am 1998;4:385-9.
11. Severin DM, Leong T, Cassidy B, et al. Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients. Int J Radiat Oncol Biol Phys 2001;50:1323-31.
12. Iannuzzi CM, Atencio DP, Green S, Stock RG, Rosenstein BS. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys 2002;52:606-13.
13. Andreassen CN, Alsner J, Overgaard M, Overgaard J. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 2003;69:127-35.
14. Andreassen CN, Alsner J, Overgaard J, et al. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol 2005;75:18-21.
15. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
16. Azria D, Gourgou S, Sozzi WJ, et al. Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. Br J Cancer 2004;91:1251-60.
17. Qiu P, Shandilya H, D'Alessio JM, O'Connor K, Durocher J, Gerard GF. Mutation detection using Surveyor nuclease. Biotechniques 2004;36:702-7.
18. Bannwarth S, Procaccio V, Paquis-Flucklinger V. Surveyor Nuclease: a new strategy for a rapid identification of heteroplasmic mitochondrial DNA mutations in patients with respiratory chain defects. Hum Mutat 2005;25:575-82.
19. Shi R, Otomo K, Yamada H, Tatsumi T, Sugawara I. Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutations in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC, SURVEYOR nuclease. Microbes Infect 2006;8:128-35.
20. Janne PA, Borras AM, Kuang Y, et al. A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening. Clin Cancer Res 2006;12:751-8.
21. Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meetsmolecular pathology. Nat Rev Cancer 2006;6:702-13.
22. Rodemann HP, Blaese MA. Responses of normal cells to ionizing radiation. Semin Radiat Oncol 2007; 17:81-8.
23. Lawrence DA. Latent-TGF-β: an overview. Mol Cell Biochem 2001;219:163-70.
24. Milliat F, Francois A, Isoir M, et al. Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages. Am J Pathol 2006;169:1484-95.
25. Moullan N, Cox DG, Angele S, Romestaing P, Gerard JP, Hall J. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 2003;12:1168-74.
26. Azria D, Pelegrin A, Dubois JB, Mirimanoff RO, Ozsahin M. Radiation therapy and tamoxifen: concurrent or sequential? It's no longer the question! J Clin Oncol 2005;23:4239-41.
27. Azria D, Rosenstein BS, Ozsahin M. Radiation-induced side-effects with or without systemic therapies: Primetime for prediction of individual radiosensitivity! Int J Radiat Oncol Biol Phys 2008;71:1293-4.